The stock of CryoPort Inc (NASDAQ: CYRX) has decreased by -11.74 when compared to last closing price of 7.88. Despite this, the company has experienced a -15.29% fall in its stock price over the last five trading sessions. prnewswire.com reported 2024-10-07 that The IntegriCell Platform Will Deliver High-Quality Cryopreservation Services for Cell-Based Therapies NASHVILLE, Tenn., Oct. 7, 2024 /PRNewswire/ — Cryoport, Inc. (NASDAQ: CYRX) (“Cryoport” or “the Company”), a global leader in supply chain solutions for the life sciences, today announced the launch of its IntegriCell™ cryopreservation services solution provided by Cryoport Systems with the opening of its new facility located at Cryoport’s integrated supply chain campus in Houston, Texas.
Is It Worth Investing in CryoPort Inc (NASDAQ: CYRX) Right Now?
CYRX has 36-month beta value of 1.61. Analysts have mixed views on the stock, with 3 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for CYRX is 47.71M, and currently, short sellers hold a 6.10% ratio of that float. The average trading volume of CYRX on October 09, 2024 was 700.53K shares.
CYRX’s Market Performance
CYRX stock saw a decrease of -15.29% in the past week, with a monthly decline of -9.68% and a quarterly a decrease of 25.32%. The volatility ratio for the week is 8.05%, and the volatility levels for the last 30 days are 6.52% for CryoPort Inc (CYRX). The simple moving average for the last 20 days is -13.95% for CYRX stock, with a simple moving average of -43.94% for the last 200 days.
Analysts’ Opinion of CYRX
Many brokerage firms have already submitted their reports for CYRX stocks, with Jefferies repeating the rating for CYRX by listing it as a “Hold.” The predicted price for CYRX in the upcoming period, according to Jefferies is $8 based on the research report published on August 07, 2024 of the current year 2024.
B. Riley Securities, on the other hand, stated in their research note that they expect to see CYRX reach a price target of $15, previously predicting the price at $19. The rating they have provided for CYRX stocks is “Buy” according to the report published on July 31st, 2024.
B. Riley Securities gave a rating of “Neutral” to CYRX, setting the target price at $19 in the report published on May 03rd of the current year.
CYRX Trading at -16.75% from the 50-Day Moving Average
After a stumble in the market that brought CYRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -65.41% of loss for the given period.
Volatility was left at 6.52%, however, over the last 30 days, the volatility rate increased by 8.05%, as shares sank -10.83% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -23.32% lower at present.
During the last 5 trading sessions, CYRX fell by -15.29%, which changed the moving average for the period of 200-days by -55.56% in comparison to the 20-day moving average, which settled at $8.08. In addition, CryoPort Inc saw -55.10% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CYRX starting from Hariri Robert J, who sale 1,000 shares at the price of $9.46 back on Aug 19 ’24. After this action, Hariri Robert J now owns 23,061 shares of CryoPort Inc, valued at $9,465 using the latest closing price.
Hariri Robert J, the Director of CryoPort Inc, sale 1,000 shares at $9.00 during a trade that took place back on Aug 16 ’24, which means that Hariri Robert J is holding 23,561 shares at $9,000 based on the most recent closing price.
Stock Fundamentals for CYRX
Current profitability levels for the company are sitting at:
- -0.32 for the present operating margin
- 0.38 for the gross margin
The net margin for CryoPort Inc stands at -0.76. The total capital return value is set at -0.09. Equity return is now at value -36.54, with -18.33 for asset returns.
Based on CryoPort Inc (CYRX), the company’s capital structure generated 0.49 points at debt to capital in total, while cash flow to debt ratio is standing at -0.03. The debt to equity ratio resting at 0.94. The interest coverage ratio of the stock is -13.88.
Currently, EBITDA for the company is -31.16 million with net debt to EBITDA at -6.88. When we switch over and look at the enterprise to sales, we see a ratio of 3.11. The receivables turnover for the company is 5.62for trailing twelve months and the total asset turnover is 0.26. The liquidity ratio also appears to be rather interesting for investors as it stands at 8.38.
Conclusion
To put it simply, CryoPort Inc (CYRX) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
